An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
Active, not recruiting · NCT06488924 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Mucopolysaccharidosis III, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous mucinosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT06488924 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| JCR Pharmaceuticals Co., Ltd. | 8 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hiroshima University Hospital | Hiroshima | Japan | 13 |
| Mie University Hospital | Tsu | Japan | 5 |
| National Center for Child Health and Development | Tokyo | Japan | 7 |
| University of the Ryukyus Hospital | Okinawa | Japan | 4 |